Studien - Niere
   
 

     
AUO Nr.: AN 39/16  Niere   Details zur Studie         
Titel: Keynote-426 - A Phase III Randomized, Open-label Study to Evaluate Efficacy and Safety of Pembrolizumab (MK-3475) in Combination with Axitinib versus Sunitinib Monotherapy as a First-line Treatment for Locally Advanced or Metastatic Renal Cell Carcinoma (mRCC)
Studienleiter: Herr Prof. Dr. med. Jens Bedke - Universitätsklinik Tübingen  72076 Tübingen Hoppe-Seyler-Str. 3 Tel:07071/29-86 613  jens.bedke@med.uni-tuebingen.de

     
AUO Nr.: AN 40/16  Niere   Details zur Studie         
Titel: Keynote-427 - A Phase II Single-arm, Open-label Monotherapy Clinical Trial of Pembrolizumab (MK-3475) in Locally Advanced/Metastatic Renal Cell Carcinoma (mRCC)
Studienleiter: Herr Prof. Dr. med. Jens Bedke - Universitätsklinik Tübingen  72076 Tübingen Hoppe-Seyler-Str. 3 Tel:07071/29-86 613  jens.bedke@med.uni-tuebingen.de